<DOC>
	<DOCNO>NCT00965757</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety T-614 versus placebo add ongoing , stable-dose methotrexate therapy patient persistently active rheumatoid arthritis</brief_summary>
	<brief_title>A Multicenter , Randomized , Double-blind , Placebo-controlled Study Combination Therapy T-614 Methotrexate Rheumatoid Arthritis Patients With Inadequate Response Methotrexate</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Inclusion criterion : Subjects diagnosis Rheumatoid Arthritis ACR criterion Age great 20 year less 70 year old Exclusion criterion : Subject consider investigator , reason , unsuitable candidate study Women childbearing potential practicing successful method contraception , wish become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>